Curcumin in HNSCC can simultaneously suppress multiple ICs, including PD-L2, demonstrating the ability to reduce the intrinsic expression of PD-L2 independently of immune cells and to inhibit EMT, potentially exceeding the efficacy of monoclonal antibodies targeting a single IC [72]. Here, PDCD1LG2 is linked to head and neck squamous cell carcinoma.